Duchenne Muscular Dystrophy - CRISPR technology

20 January 2020

The Yale School of Medicine is using CRISPR technology to develop the first ever treatment for Duchenne Muscular Dystrophy.

Research in mice has found that CRISPR gene editing may provide a method for lifelong correction of the genetic mutation in DMD and potentially other muscle diseases.

To read more: https://www.wtnh.com/lifestyle/health-news/yale-school-of-medicine-developing-first-ever-treatment-for-duchenne-muscular-dystrophy/?fbclid=IwAR2d0tfT6GRlzR4OaUp7fOCzIZOrl40e0mgQyun0db0oosudh3tO7LPOl9M